Ibrutinib, the first-generation Bruton tyrosine kinase inhibitor, has well-documented cardiovascular effects that influence treatment decisions for patients with chronic lymphocytic leukemia. This quiz...
Core needle biopsy accuracy varies by lymphoma subtype. Which one yields the highest diagnostic sensitivity? Test your knowledge of hematologic pathology.
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
How well do you understand the latest findings on fixed-duration acalabrutinib–venetoclax regimens in untreated chronic lymphocytic leukemia? Take this quiz to find out!
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
Chronic lymphocytic leukemia (CLL) is a complex disease with risk factors rooted in genetics, environmental exposures, and precursor conditions. How well do you understand the latest insights into CLL...
A recent review highlights key genetic abnormalities in chronic lymphocytic leukemia which predict faster disease progression and treatment resistance. Test your knowledge!
Risk factors may give a clinician an idea of the chance their patient has of developing a disease, like chronic lymphocytic leukemia (CLL). There are few known risk factors linked to CLL. Do you know which...
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
